Related Experiment Videos
Pretreatment attrition and childhood social phobia: Parental concerns about medication
Brennan J Young1, Deborah C Beidel, Samuel M Turner
1Maryland Center for Anxiety Disorders, Department of Psychology, University of Maryland, College Park, MD, USA. byoung7@du.edu
Abstract:
Pretreatment attrition, the systematic self-exclusion of potential participants during the recruitment phase of a study, poses a significant threat to the external validity of randomized clinical trials. Very little is known about the factors that contribute to pretreatment attrition, especially among families seeking treatment for a child. The current study assessed pretreatment attrition in a randomized clinical trial of behavior therapy, fluoxetine, and placebo for child and adolescent social phobia. Reluctance toward medication treatment accounted for 44.7% of study refusals and was disproportionately common among ethnic minority families. Parents were particularly worried about the potential for side effects or physical/psychological dependency upon the medication. Results are discussed in terms of the implications for external validity in future psychopharmacological clinical trials.
Related Concept Videos
Social Anxiety Disorder
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Drug Therapy
Antianxiety Medications
Psychological and Sociocultural Causes of Schizophrenia
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Relationship with Parents: Attachment